207 related articles for article (PubMed ID: 8906943)
1. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Dalal PM; Dalal KP
J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Sood AK; Dua A; Mahajan A; Arora S
J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
[No Abstract] [Full Text] [Related]
3. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
Nag D; Garg RK; Varma M
Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
[TBL] [Abstract][Full Text] [Related]
4. Update on calcium antagonists in cerebrovascular diseases.
Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
[TBL] [Abstract][Full Text] [Related]
5. [Calcium channel blockers in therapy of neurologic diseases].
Wessely P; Wöber-Bingöl C
Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
[TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
7. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
[TBL] [Abstract][Full Text] [Related]
8. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
Di Mascio R; Marchioli R; Tognoni G
Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
10. [The effects of nimodipine on cerebrovascular function in acute cerebral infarction].
Long J; Wang G; Bai Y
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):679-81. PubMed ID: 11038793
[TBL] [Abstract][Full Text] [Related]
11. Prior calcium-channel antagonist use and ischemic stroke outcomes.
Welty TE
Ann Pharmacother; 1994 May; 28(5):671. PubMed ID: 8069009
[No Abstract] [Full Text] [Related]
12. [The usage of calcium channel blockers in acute cerebral ischemia].
Ara JR; Errea JM; Calderón C; Marzo ME; Serrano C; Hermida I
Rev Neurol; 1995; 23(120):450. PubMed ID: 7497207
[No Abstract] [Full Text] [Related]
13. Nimodipine: drug pharmacokinetics and plasma adenosine levels in patients affected by cerebral ischemia.
Blardi P; Urso R; De Lalla A; Volpi L; Perri TD; Auteri A
Clin Pharmacol Ther; 2002 Nov; 72(5):556-61. PubMed ID: 12426519
[TBL] [Abstract][Full Text] [Related]
14. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
van den Bergh WM; Mees SM; Rinkel GJ
Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
[No Abstract] [Full Text] [Related]
15. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke.
Ahmed N; Näsman P; Wahlgren NG
Stroke; 2000 Jun; 31(6):1250-5. PubMed ID: 10835440
[TBL] [Abstract][Full Text] [Related]
16. New aspects of calcium antagonists for treatment of cerebrovascular disease.
Hennerici MG
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S59-63. PubMed ID: 1725006
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
Kazda S; Garthoff B; Krause HP; Schlossmann K
Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
[TBL] [Abstract][Full Text] [Related]
18. Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke.
Gelmers HJ
Am J Cardiol; 1985 Jan; 55(3):144B-148B. PubMed ID: 2578724
[TBL] [Abstract][Full Text] [Related]
19. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
20. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
